CACATIAN, SALVACION,CLAREMON, DAVID A.,DILLARD, LAWRENCE WAYNE,DONG, CHENGGUO,FAN, YI,JIA, LANQI,LOTESTA, STEPHEN D.,MARCUS, ANDREW,MORALES-RAMOS, ANGEL,SINGH, SURESH B.,VENKATRAMAN, SHANKAR,YUAN, JIN
申请号：
CA3024180
公开号：
CA3024180A1
申请日:
2017.06.08
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
